Erba, H. P., Patkowska, E., Cortes, J., Perl, A. E., Sekeres, M. A., Dombret, H., … Montesinos, P. (2024). QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML). In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 24, pp. S299–S299).

Erba, Harry P., Elzbieta Patkowska, Jorge Cortes, Alexander E. Perl, Mikkael A. Sekeres, Herve Dombret, Sergio Amadori, et al. “QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML).” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 24:S299–S299, 2024.

Erba HP, Patkowska E, Cortes J, Perl AE, Sekeres MA, Dombret H, et al. QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML). In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S299–S299.

Erba, Harry P., et al. “QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML).” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 24, 2024, pp. S299–S299.

Erba HP, Patkowska E, Cortes J, Perl AE, Sekeres MA, Dombret H, Amadori S, Wang J, Levis MJ, Schlenk RF, Liu L, Kamel YM, Imadalou K, Laadem A, Lesegretain A, Montesinos P. QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S299–S299.